Adams DW, Moleski S, Jossen J, Tye-Din JA. Reply to Rockey and Ko. Gastroenterology. 2024;:10.1053/j.gastro.2024.07.019
Thomson RL, Oakey H, Haynes A, Craig ME, Harrison LC, Wentworth JM, Anderson A, Ashwood P, Barry S, Brittain B, Brown JD, Colman PG, Davis EA, Hamilton-Williams E, Huynh D, Huynh T, Kim K-W, McGorm KJ, Morahan G, Rawlinson W, Sinnott RO, Soldatos G, Tye-Din JA, Vuillermin PJ, Penno MAS, Couper JJ. Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information. BMJ Open Diabetes Research & Care. 2024;12(4):10.1136/bmjdrc-2024-004130
Saitta D, Henneken LM, Apputhurai P, Chen Yi Mei SL, Tye-Din JA. Budesonide Induces Favourable Histologic and Symptomatic Recovery in Patients with Non-responsive and Refractory Coeliac Disease When Given in an Open Capsule Format. Digestive Diseases and Sciences. 2024;69(7):10.1007/s10620-024-08436-3
Hardy MY, Henneken LM, Russell AK, Okura Y, Mizoroki A, Ozono Y, Kobayashi S, Murakami Y, Tye-Din JA. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease. Clinical Immunology. 2024;264:10.1016/j.clim.2024.110259
Saitta D, Henneken LM, Apputhurai P, Chen Yi Mei SL, Tye-Din JA. Correction to: Budesonide Induces Favourable Histologic and Symptomatic Recovery in Patients with Non-responsive and Refractory Coeliac Disease When Given in an Open Capsule Format. Digestive Diseases and Sciences. 2024;69(7):10.1007/s10620-024-08510-w
Tye‐Din JA. Evolution in coeliac disease diagnosis and management. JGH Open. 2024;8(7):10.1002/jgh3.13107
Silvester JA, Elli L, Khosla C, Tye-Din JA. Past, Present, and Future of Noninvasive Tests to Assess Gluten Exposure, Celiac Disease Activity, and End-Organ Damage. Gastroenterology. 2024;167(1):10.1053/j.gastro.2024.01.053
Henneken LM, Loh TJ, Ciacchi L, Ciacchi L, Lim J, Reid HH, Tye‐Din JA. Bridging science and accessibility: a tactile journey from gluten through to coeliac disease. Immunology and Cell Biology. 2024;102(5):10.1111/imcb.12716
Knowles SR, Apputhurai P, Tye‐Din JA. Development and validation of a brain fog scale for coeliac disease. Alimentary Pharmacology & Therapeutics. 2024;59(10):10.1111/apt.17942
Saitta D, Henneken L, Apputhurai P, Mei SLGCY, Tye-Din JA. EP52 PROXIMAL SMALL INTESTINAL DELIVERY OF TOPICAL BUDESONIDE INDUCES SIGNIFICANT HISTOLOGIC AND SYMPTOMATIC RECOVERY IN PATIENTS WITH NON-RESPONSIVE AND REFRACTORY CELIAC DISEASE. Gastroenterology. 2024;166(5):10.1016/s0016-5085(24)03942-8
